325 related articles for article (PubMed ID: 35844571)
1. Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases.
Ikutani M; Nakae S
Front Immunol; 2022; 13():939378. PubMed ID: 35844571
[TBL] [Abstract][Full Text] [Related]
2. Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.
Jin J; Sunusi S; Lu H
J Int Med Res; 2022 Jan; 50(1):3000605211053156. PubMed ID: 35048721
[TBL] [Abstract][Full Text] [Related]
3. Trained innate lymphoid cells in allergic diseases.
Ebihara T; Tatematsu M; Fuchimukai A; Yamada T; Yamagata K; Takasuga S; Yamada T
Allergol Int; 2021 Apr; 70(2):174-180. PubMed ID: 33328130
[TBL] [Abstract][Full Text] [Related]
4. T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production.
Zhu J
Cytokine; 2015 Sep; 75(1):14-24. PubMed ID: 26044597
[TBL] [Abstract][Full Text] [Related]
5. IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic tone and suppressed by obesity.
Ding X; Luo Y; Zhang X; Zheng H; Yang X; Yang X; Liu M
J Endocrinol; 2016 Oct; 231(1):35-48. PubMed ID: 27562191
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
7. IL-13
Jia Y; Fang X; Zhu X; Bai C; Zhu L; Jin M; Wang X; Hu M; Tang R; Chen Z
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):675-683. PubMed ID: 27314535
[TBL] [Abstract][Full Text] [Related]
8. [The role of group 2 innate lymphoid cells (ILC2) in respiratory allergic diseases: An update].
Luo C; Liu S; Ren Q; Peng S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):552-557. PubMed ID: 37340924
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
10. Role of type 2 innate lymphoid cell and its related cytokines in tumor immunity.
Wan J; Cai W; Wang H; Cheng J; Su Z; Wang S; Xu H
J Cell Physiol; 2020 Apr; 235(4):3249-3257. PubMed ID: 31625163
[TBL] [Abstract][Full Text] [Related]
11. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of type 2 innate lymphoid cells.
Spits H; Mjösberg J
Nat Rev Immunol; 2022 Nov; 22(11):701-712. PubMed ID: 35354980
[TBL] [Abstract][Full Text] [Related]
13. IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice.
Hosotani Y; Yasuda K; Nagai M; Yamanishi K; Kanazawa N; Gomi F; Imai Y
Allergol Int; 2023 Apr; 72(2):324-331. PubMed ID: 37010996
[TBL] [Abstract][Full Text] [Related]
14. Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy.
Ikutani M; Tsuneyama K; Kawaguchi M; Fukuoka J; Kudo F; Nakae S; Arita M; Nagai Y; Takaki S; Takatsu K
JCI Insight; 2017 Apr; 2(7):e90721. PubMed ID: 28405615
[TBL] [Abstract][Full Text] [Related]
15. Transcription Factors in the Development and Function of Group 2 Innate Lymphoid Cells.
Ebihara T; Taniuchi I
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893794
[TBL] [Abstract][Full Text] [Related]
16. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
van Rijt L; von Richthofen H; van Ree R
Semin Immunopathol; 2016 Jul; 38(4):483-96. PubMed ID: 26965110
[TBL] [Abstract][Full Text] [Related]
17. At the bench: understanding group 2 innate lymphoid cells in disease.
Doherty TA
J Leukoc Biol; 2015 Mar; 97(3):455-67. PubMed ID: 25473099
[TBL] [Abstract][Full Text] [Related]
18. Systemic administration of IL-33 induces a population of circulating KLRG1
Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ
Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462
[TBL] [Abstract][Full Text] [Related]
19. Group 2 innate lymphoid cells in the regulation of immune responses.
Roediger B; Weninger W
Adv Immunol; 2015; 125():111-54. PubMed ID: 25591466
[TBL] [Abstract][Full Text] [Related]
20. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
[Next] [New Search]
